Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - Edesa Biotech, Inc. | tv495777_ex5-1.htm |
| S-1 - FORM S-1 - Edesa Biotech, Inc. | tv495777_s1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 of Stellar Biotechnologies, Inc. of our
report dated December 1, 2017, except for the effects of the share consolidation disclosed in Note 12 – Subsequent Events
to the consolidated financial statements, as to which the date is May 7, 2018, relating to the consolidated financial statements
of Stellar Biotechnologies, Inc., which appears on page F-2 in Amendment No. 1 to the Registration Statement on Form S-1 of Stellar
Biotechnologies, Inc., filed with the Securities and Exchange Commission on May 8, 2018 (Registration No. 333-224314), and to the
reference to our firm under the heading “Experts” in the Prospectus, which is part of this Registration Statement.
/s/ Moss Adams LLP
Los Angeles, California
June 5, 2018